• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

powerROC:用于评估模型鉴别能力时样本量计算的交互式网络工具。

powerROC: An Interactive Web Tool for Sample Size Calculation in Assessing Models' Discriminative Abilities.

作者信息

Grolleau François, Tibshirani Robert, Chen Jonathan H

机构信息

Stanford Center for Biomedical Informatics Research, Stanford University.

Department of Statistics, Stanford University.

出版信息

AMIA Jt Summits Transl Sci Proc. 2025 Jun 10;2025:196-204. eCollection 2025.

PMID:40502274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12150715/
Abstract

Rigorous external validation is crucial for assessing the generalizability of prediction models, particularly by evaluating their discrimination (AUROC) on new data. This often involves comparing a new model's AUROC to that of an established reference model. However, many studies rely on arbitrary rules of thumb for sample size calculations, often resulting in underpowered analyses and unreliable conclusions. This paper reviews crucial concepts for accurate sample size determination in AUROC-based external validation studies, making the theory and practice more accessible to researchers and clinicians. We introduce powerROC, an open-source web tool designed to simplify these calculations, enabling both the evaluation of a single model and the comparison of two models. The tool offers guidance on selecting target precision levels and employs flexible approaches, leveraging either pilot data or user-defined probability distributions. We illustrate powerROC's utility through a case study on hospital mortality prediction using the MIMIC database.

摘要

严格的外部验证对于评估预测模型的通用性至关重要,特别是通过在新数据上评估其区分度(AUROC)。这通常涉及将新模型的AUROC与既定参考模型的AUROC进行比较。然而,许多研究在样本量计算方面依赖任意的经验法则,常常导致分析效能不足和结论不可靠。本文回顾了基于AUROC的外部验证研究中准确确定样本量的关键概念,使研究人员和临床医生更容易理解相关理论和实践。我们介绍了powerROC,这是一个开源网络工具,旨在简化这些计算,能够对单个模型进行评估并比较两个模型。该工具为选择目标精度水平提供指导,并采用灵活的方法,利用试点数据或用户定义的概率分布。我们通过使用MIMIC数据库进行医院死亡率预测的案例研究来说明powerROC的效用。

相似文献

1
powerROC: An Interactive Web Tool for Sample Size Calculation in Assessing Models' Discriminative Abilities.powerROC:用于评估模型鉴别能力时样本量计算的交互式网络工具。
AMIA Jt Summits Transl Sci Proc. 2025 Jun 10;2025:196-204. eCollection 2025.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Audit and feedback: effects on professional practice.审核与反馈:对专业实践的影响
Cochrane Database Syst Rev. 2025 Mar 25;3(3):CD000259. doi: 10.1002/14651858.CD000259.pub4.
8
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.

本文引用的文献

1
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods.TRIPOD+AI 声明:报告使用回归或机器学习方法的临床预测模型的更新指南。
BMJ. 2024 Apr 16;385:e078378. doi: 10.1136/bmj-2023-078378.
2
Evaluation of clinical prediction models (part 3): calculating the sample size required for an external validation study.临床预测模型评估(第3部分):计算外部验证研究所需的样本量。
BMJ. 2024 Jan 22;384:e074821. doi: 10.1136/bmj-2023-074821.
3
There is no such thing as a validated prediction model.没有经过验证的预测模型这种东西。
BMC Med. 2023 Feb 24;21(1):70. doi: 10.1186/s12916-023-02779-w.
4
MIMIC-IV, a freely accessible electronic health record dataset.MIMIC-IV,一个可自由访问的电子健康记录数据集。
Sci Data. 2023 Jan 3;10(1):1. doi: 10.1038/s41597-022-01899-x.
5
Availability and reporting quality of external validations of machine-learning prediction models with orthopedic surgical outcomes: a systematic review.机器学习预测模型在骨科手术结局中的外部验证的可用性和报告质量:系统评价。
Acta Orthop. 2021 Aug;92(4):385-393. doi: 10.1080/17453674.2021.1910448. Epub 2021 Apr 18.
6
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal.COVID-19 诊断和预后预测模型:系统评价和批判性评估。
BMJ. 2020 Apr 7;369:m1328. doi: 10.1136/bmj.m1328.
7
Calculating the sample size required for developing a clinical prediction model.计算开发临床预测模型所需的样本量。
BMJ. 2020 Mar 18;368:m441. doi: 10.1136/bmj.m441.
8
Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal.慢性阻塞性肺疾病患者结局预测的预后模型:系统评价和批判性评估。
BMJ. 2019 Oct 4;367:l5358. doi: 10.1136/bmj.l5358.
9
Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes.建立多变量预测模型的最小样本量:第二部分 - 二分类和生存数据。
Stat Med. 2019 Mar 30;38(7):1276-1296. doi: 10.1002/sim.7992. Epub 2018 Oct 24.
10
Prediction models for cardiovascular disease risk in the general population: systematic review.普通人群心血管疾病风险预测模型:系统评价
BMJ. 2016 May 16;353:i2416. doi: 10.1136/bmj.i2416.